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Comparison of walking performance over the first
2 minutes and the full 6 minutes of the Six-Minute
Walk Test
Richard W Bohannon1, Deborah Bubela1*, Susan Magasi2,6, Heather McCreath3, Ying-Chih Wang4, David Reuben3,
William Z Rymer5 and Richard Gershon2
Abstract
Background: Although the Six-Minute Walk Test (6MWT), as recommended by the American Thoracic Society, is
widely used as a measure of functional endurance, it may not be applicable in some settings and populations. We
sought to examine, therefore, performance over the first 2 minutes and the full 6 minutes of the 6MWT. Specifically,
we investigated completion rates, distances walked, test-retest reliability, and the relationship between distances
walked over the first 2 and the full 6 minutes of the 6MWT.
Methods: Community-dwelling children and adults age 3–85 years (n = 337) were asked to walk back and forth on
a 15.24 meter (50 ft) course as far as possible without running over a 6 minute period. Test completion and the
distance covered by the participants at 2 and 6 minutes were documented. The reliability of distances covered at 2
and 6 minutes was determined by retesting a subsample of 54 participants 6 to 10 days later. The relationship
between distances covered at 2 and 6 minutes was determined for the 330 participants completing the 6MWT.
Results: All 337 participants completed at least 2 minutes of walking, but 7 children less than 5 years of age ceased
walking before 6 minutes had elapsed. For the remaining 330 participants the mean distance walked was 186
meters at 2 minutes and 543 meters at 6 minutes. The distances covered at 2 and 6 minutes were reliable between
sessions (intraclass correlation coefficients = 0.888 and 0.917, respectively). The distances covered over 2 and
6 minutes were highly correlated (r = 0.968).
Conclusions: The completion rate, values obtained, test-retest reliability, and relationship of the distances walked in
2 and 6 minutes support documentation of 2 minute distance during the 6MWT. The findings also provide support
for use of a Two-Minute Walk Test as the endurance component in the Motor Battery of the NIH Toolbox.
Background
Functional endurance is necessary for individuals to live
independently without accommodation in community
settings [1]. Walk tests, in which the distance covered
over a period of time is documented, have been used
since at least the 1970s to quantify functional endurance
[2]. Though most widely used among patients with pul-
monary [2-4] or cardiac [5,6] diagnoses, walk tests have
also been employed for patients with neurologic problems
[7,8], amputations [9], circulatory insufficiency [10], ortho-
pedic conditions [11] and renal [12] or liver [13] disease.
The tests have been utilized with community-dwelling
children [14,15] and adults [16,17] as well. Walk tests de-
scribed in the literature range in duration from 1 to 12
minutes [2,3,8], but the Six-Minute Walk Test (6MWT)
is probably the most frequently used. The American
Thoracic Society has recommended the 6MWT and pub-
lished guidelines for its administration [18].
Broad use and the American Thoracic Society’s recom-
mendation notwithstanding, the duration of the 6MWT
renders its use impracticable in busy settings- particu-
larly if numerous individuals need to be tested over a
limited time span. Moreover, some individuals are una-
ble or unwilling to complete the 6MWT, even with allo-
wable standing rests [19-21], resulting in null values. This
fact has led to the use and recommendation of shorter
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duration walk tests- most notably the Two-Minute Walk
Test (2MWT) [19,20,22]. To date, the completion of 2 mi-
nutes of walking and the distance walked over 2 minutes
has not been documented over the 3 to 85 year age span.
Good intra-rater and interrater reliability have been de-
scribed for distances achieved during 2MWTs, at least for
older adults residing in long-term care [20] and patients
with stroke [7]. However, the reliability of distances co-
vered during the first 2 minutes of the 6MWT has not
been described. Distances traversed during a 2MWT and
6MWT have been shown to be highly correlated (r =
0.930-0.997) [4,7,20,23], but the relationship between the
distance walked during the first 2 minutes of the 6MWT
and the distance covered over the full course of the
6MWT is not established. If the completion rate for
2 minutes of walking surpasses that of 6 minutes of
walking and if the distance covered during the first
2 minutes of the 6MWT is reliable and strongly re-
lated to the 6MWT distance, measurement of the dis-
tance covered in the first 2 minutes might be justified
and perhaps considered as a substitute for the 6MWT dis-
tance. The purpose of this study, therefore, was to de-
scribe completion rates and distance walked, determine
the test-retest reliability for the distances walked, and as-
certain the relationship between the distance walked in
the first 2 minutes and full 6 minutes of the 6MWT.
Methods
This investigation was part of the validation phase of
the Motor Domain of the National Institutes of Health
(NIH) Toolbox for the Assessment of Neurological and
Behavioral Function (NIH Toolbox) study [24]. It in-
cluded data gathered from convenience samples tested
at 3 participating sites (University of Connecticut, Reha-
bilitation Institute of Chicago, and University of California
Los Angeles). The institutional review boards from each
site approved the study. All participants or their legal
guardians provided written informed consent before tes-
ting. Participants were 3–85 years of age. Inclusion re-
quired that participants were fluent in English, were able
to walk without use of an assistive device, and had no
heart, vascular, lung, or bone/joint problems that preclu-
ded their ability to walk independently.
Prior to obtaining candidate measures for the NIH
Toolbox, basic demographic (age, gender), anthropomet-
ric (height, weight [body mass index]), and health status
information was obtained along with baseline heart-rate
and blood pressure measurements. Thereafter, in ran-
dom order, participants completed the 6MWT as either
the first or last task of the larger battery of tests. Parti-
cipants were asked to walk as far as possible without
running for 6 minutes. They walked on a flat, hard and
straight 15.24 meter (50 foot) course marked on both
ends with traffic cones. At 1 minute intervals they were
told that they were “doing well” or to “keep up the good
work” and informed of the time remaining. Participants
were allowed to take a standing rest if they chose to do
so at any point, but were asked to resume walking if and
when possible until the 6 minute period had elapsed.
The distances covered in 2 and 6 minutes were docu-
mented. A subset of 54 participants distributed across
age and sex strata repeated the walk tests within a 6–10
day interval to examine test-retest reliability of the mea-
sures. These participants were the first who agreed to re-
turn for retesting.
Performance over the course of the 6MWT and across
the age-span was first described by noting the number
of participants not completing the 6MWT. For individ-
uals completing the 6MWT descriptive statistics (range,
mean, standard deviation, and confidence intervals) were
calculated for the distances walked in 2 and 6 minutes.
Intraclass correlation coefficients (ICCs) were used to
describe the reliability of the distances walked in 2 and
6 minutes. A Pearson correlation and linear regression
were used to determine the relationship between the dis-
tances covered over the first 2 and the total 6 minutes of
the 6MWT. Statistical analyses were completed using
SPSS 15.0 with an alpha level of 0.05.
Results
Table 1 summarizes demographic and other nonperfor-
mance data describing the 330 participants who com-
pleted the 6MWT. Approximately 55% of the participants
were female and about 35% identified their race as other
than White. Most participants reported their health to be
excellent (49%) or very good (36%).
Seven of 337 individuals (2.1%) who enrolled in the
study did not complete the 6MWT. All 7 were less than
5 years old. One (0.3%) of the 7 refused to attempt
the task. The other 6 (1.8%) walked at least 2 minutes
but stopped before 6-minutes had elapsed and declined
to resume walking for nonphysical reasons (e.g., averted
attention).
For the 330 individuals completing the 6MWT, only 1
required a standing rest stop. The distance walked over
the course of 2 minutes was 186 ± 34 (91–290) meters.
Over the full 6 minutes the distance walked was 543 ±
102 (258–823) meters. Individual performance varied
considerably (Figure 1). Only participants aged less than
7 years or more than 74 years walked 135 meters or less
in 2 minutes (n = 23) or 396 meters or less in 6 minutes
(n = 22) (Figure 2). Excellent test-retest reliability was
demonstrated for the distances covered over the first
2 minutes (ICC = 0.888 [0.814- = 0.933]) and the full
6 minutes (ICC = 0.917 [0.862-0.951]) of the 6MWT.
The distances covered over 2 and 6 minutes were corre-
lated highly (r = 0.968, p < 0.0001). The linear regression
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equation describing the relationship was: 6MWT distance
(meters) = 27 meters + 2.87*2 minute distance (meters).
Discussion
Timed walk tests are commonly used to measure the func-
tional endurance of diverse populations [1-23]. Among
such tests, the 6MWT, as recommended by the American
Thoracic Society, is probably the most widely used. This
led to its inclusion in the validation phase of the NIH
Toolbox project [24]. In the validation phase we were par-
ticularly interested in the rate of test completion, test per-
formance, test-retest reliability, and the degree to which
the distances walked over earlier minutes of the test were
reflective of the distance covered over the full 6-minute
duration of the 6MWT.
The completion rate we observed for the 6MWT was
97.9%. Only individuals less than 5 years old failed to
complete the test. The completion rate among the children
we tested was less than the 100% reported by Lammers
et al. for 4–11 year old children [14] and greater than the
82.5% reported by Geiger et al. for boys and girls 3–18
years of age [21]. Among a subset of children 3–5 years of
age in their study, Geiger et al. reported a “response rate”
of only 39%, though they did not operationalize “response
rate”. All of the community-dwelling older adults we stu-
died completed the 6MWT. Our sample, therefore, was
more able than that of Brooks et al. [19]. Of their older
adults, who were undergoing rehabilitation, only 1 of 8
was able to walk for 6 minutes. As a consequence they
abandoned further testing with the 6MWTand resorted to
using a 2MWT. Fifty of 52 older adults tested by Brooks
et al. were able to complete a 2MWT. Gijbels et al., who
tested patients with multiple sclerosis, have suggested that
“the last 4-minute period of the 6MWT seems redundant”
[23]. Together these findings support the measurement of
distance walked over 2 minutes, whether it be the first
2 minutes of a 6MWT or a 2MWT. By capturing the dis-
tance walked over 2 minutes null values might be avoided
in clinical documentation and research trials.
We documented the distances walked by our conveni-
ence sample of participants over 6 minutes and over the
first 2 minutes of the 6MWT. We used a back-and-forth
distance of 15.2 meters rather than the 30.5 meter dis-
tance recommended by the American Thoracic Society
[18] as we judged it to be more ecologically generali-
zable. Although a greater frequency of turns has the po-
tential to suppress the distance walked over time [25],
the distances we report for 6 minutes appear to be re-
latively comparable to those reported by others testing
able-bodied children and adults [14,26-29]. Specifically,
the mean distance walked by children (3–11 years) in
our study was 510 meters compared to 470 ± 59 meters
in the study of Lammers et al. [14]. The median distance
covered by adults (40 or more years) in our study was
Table 1 Number (%) of participants completing walk task
by demographic characteristics
Variable N (%)
Site*
University of Connecticut 137 (41.5)
Rehabilitation Institute of Chicago 116 (35.2)
University of California, Los Angeles 77 (23.3)
Total 330 (100)
Gender
Female 180 (54.5)
Male 150 (45.5)
Age (yrs) strata per study design*
3-6 58 (17.6)
7-13 78 (23.6)
14-20 33 (10.0)
21-65 100 (30.3)
66-85 61 (18.5)
Hispanic or Latino 37 (11.2)
Race
White 211 (63.9)
Asian 50 (15.2)
Black 29 (8.8)
Other 40 (12.1)
*Due to research design features, UCLA enrolled only children.
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Figure 1 Distance walked by individual participants over
6 minutes (red) and 2 minutes (blue) of the Six-Minute
Walk Test.
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512 meters compared to 527 meters in the study of
Enright and Sherrill [29]. Regarding the distance walked
by our participants in the first 2 minutes of the 6MWT
(186 meters), it far exceeded mean 2MWT distances for
older adults in long-term care [20], patients with lower-
limb amputations [9], patients undergoing cardiac sur-
gery [22], and patients with stroke [7]. Providing add-
itional perspective, the mean distance our participants
Figure 2 Scatterplots showing the relationship between age and distance walked in 2 minutes (top) and 6 minutes (bottom) of the
Six-Minute Walk Test.
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walked in the first 2 minutes of the 6MWT also excee-
ded the mean distances required to traverse a post office
(52.0 meters), bank (57.1 meters), or medical office buil-
ding (65.8 meters); the mean distance covered over the
full 6 minutes exceeded the mean distances needed to
traverse a pharmacy (206.3 meters), department store
(345.9 meters), or grocery store (380.6 meters) [30]. So
even if we do not consider our 2-minute or 6-minute dis-
tances to be normative, they are comparable to data
obtained from other community-dwelling individuals,
greater than data obtained from patient groups, and
ecologically relevant.
By measuring performance at 2 and 6 minutes of the
6MWT on 2 occasions, we were able to examine the re-
liability of distances covered at both times. While the
ICC for 6 minutes was of greater magnitude than the
ICC for 2 minutes, both are indicative of good reliability
and fall within the confidence intervals of one another.
Moreover, the ICCs for 2 minutes are within the range of
those reported for patients with stroke (ICC = 0.85) [7]
and for older adults in long-term care (0.94 and 0.95) [20].
Although we did not separately examine participants
using a 2MWT and 6MWT, the correlation between the
distances walked at 2 and 6 minutes of the 6MWT
(0.968) is similar to correlations reported by researchers
comparing 2MWT and 6MWT performance among ol-
der adults in long-term care (0.930) [20], and patients
with multiple sclerosis (0.980) [23], stroke (0.997) [7],
and chronic obstructive pulmonary disease (0.937) [4].
Together, these findings demonstrate that the distance
walked in 2 minutes is a valid indicator of the distance
covered in 6 minutes, whether the 2 minute distance is
obtained from a 6MWT or a separate 2MWT.
This study had several limitations. First a convenience
sample of relatively healthy community-dwelling indi-
viduals was used. A population-based sample might yield
different completion rates, reliability coefficients, and rela-
tionships between distances walked. Patients with limited
aerobic capacity or pain might also demonstrate lower
completion rates. Depending on the frequency, timing,
and duration of standing rests, reliability and correlations
between distances walked at 2 and 6 minutes could be de-
pressed relative to those we found. Our study provides no
indication of the relative discriminant or predictive valid-
ity of the distance walked in 2 versus 6 minutes of
the 6MWT. Second, we only examined 2-minute walk
distance in the context of a 6MWT. The comparability of
distance walked in a 2MWT in our sample is therefore
unknown. Individuals may walk faster if they realize they
won’t have to walk another 4 minutes. Third, though our
sample was relatively large, we considered it to be too
small to perform subgroup analysis on specific strata (e.g.,
girls 3–5 years). Finally, we did not measure oxygen con-
sumption, heart rate or perceived exertion over the course
of the 6MWT. While doing so is beyond the scope of the
NIH Toolbox project, such measures can be informative
in as to specifics over the course of 6 minutes. Motl et al.,
for example, measured oxygen consumption at 30 second
intervals of the 6MWTand found that steady-state aerobic
metabolism was not reached until 3 minutes of walking
were completed in patients with multiple sclerosis [31].
Future research will involve the collection of norma-
tive data for the 2MWT across the age-span. That data
will then be used as a benchmark for various community-
dwelling and patient groups.
Conclusions
Based on completion rates, distances walked, reliability
and the high correlation between the distance walked in
2 and 6 minutes, the distance walked over 2 minutes can
be considered to be a legitimate alternative to the dis-
tance walked over 6 minutes for indicating functional
endurance among relatively healthy community-dwelling
individuals. Even if the 6MWT is used, it may be useful
to document 2-minute walk distance so that useful in-
formation is still obtained from individuals unable to
complete the full 6MWT. The 2MWT will be used as
the measure of functional endurance in the norming
phase of the NIH Toolbox project.
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